Company
Introduction Company
Introduction CEO Greeting Leadership R&D Experience History
New Drug R&D Repositioning Clinical Translational
Research
PRIINT Orthotopic Animal Model Novel Drug Development
Pileline Stautus PBS203 PBL201 PBL211
News Contribution
Notice Financial Information IR Contact
Location Study Request What We Value Corporate Culture

Pipeline

PBL201

Allostatine?

  • Hybrid Molecule of Human Ig CDR3 and Alloferon
  • Interaction of NKG2D receptor

Anti-cancer Effect of Combination Therapy

  • Validation of combination tTherapy in orthotopic pancreatic cancer model
  • Validation of chemotherapy & aAllostatine combination anti-cancer effect of targeted therapy
Orthotopic pancreatic cancer Model

Anti-cancer Effect of Targeted Therapy

  • Validation of chemotherapy & allostatine combination in liver mets colon cancer
  • Validation of chemotherapy & allostatine combination in orthotopic cancer
Colon cancer liver metastasis model
Ovarian cancer Orthotopic Animal Model

Patent Application

  • Patent Application US Patent Application Priority of pancreatic cancer combination therapy
  • Extension of indication in ovarian cancer, colon cancer and any solid Tumor